Updates from The Motley Fool

Latest updates on ArQule, Inc. from Fool.com.


Stock Performance

ARQL vs. S&P 500 | 2 Year Performance
ARQL 1-Day Stock Chart
ARQL 5-Day Stock Chart
ARQL 1-Month Stock Chart
ARQL 3-Month Stock Chart
ARQL 6-Month Stock Chart
ARQL 1-Year Stock Chart
ARQL 2-Year Stock Chart
ARQL 5-Year Stock Chart
View Interactive ARQL Charts
Sponsored by

Key Data Points

Primary metrics and data points about ArQule, Inc..
Current Price: $1.61
Prev Close: $1.63
Open: $1.62
Bid: $1.60
Ask: $1.63
Day's Range: $1.61 - $1.65
52wk Range: $1.37 - $2.65
Volume: 7,299
Avg Vol 148,447
Market Cap: $101.26M
P/E (ttm): -7.41
EPS (ttm): -$0.22
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about ArQule, Inc..
CAPS Rating 3 out of 5
 
171 Outperform
22 Underperform
CAPS All Stars
 
42 Outperform
6 Underperform

How do you think ArQule, Inc. will perform against the market?



You pick for ArQule, Inc. is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Paolo Pucci, CEO

26% Approve

Based on 3 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for ArQule, Inc..

A clinical-stage biotechnology company, engaged in the research and development of cancer therapeutics. Its mission is to research, develop and commercialize targeted cancer drugs with reduced toxicities compared to conventional cancer chemotherapeutics.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers